Respiratory Infections News

Moderna announced that it is seeking an emergency use authorization from the FDA for an additional booster dose of its COVID-19 vaccine for all adults.

What started as an outbreak of viral pneumonia that infected dozens of people in a city in central China has grown into a pandemic that has killed nearly one million people in the United States alone.

Pfizer and BioNTech announced this week that they are seeking an emergency use authorization from the FDA for an additional booster dose of their COVID-19 vaccine for older adults.

The CDC’s wastewater surveillance tracker shows that 165 U.S. sites have experienced an increase in SARS-CoV-2 levels in the last 15 days.

Surveillance data continue to show that COVID-19 hospitalizations among young children increased fivefold during the omicron wave of SARS-CoV-2 compared with the peak of the delta wave, researchers reported in MMWR.

The incidence of subclinical tuberculosis among people with HIV in a South African study was similar to the incidence of clinical TB, suggesting that guidelines recommending symptom-based screening may need to be updated, researchers said.

Select pharmacies will soon be able to provide antivirals to patients who test positive for SARS-CoV-2 on the spot at no cost through the recently announced test-to-treat initiative.

Continued use of dexamethasone after hospital discharge was not associated with a reduction in readmission or mortality among patients with COVID-19, researchers reported in JAMA Network Open.

The Pfizer-BioNTech COVID-19 vaccine reduced the risk for infection with the omicron variant of SARS-CoV-2 by 31% among children aged 5 to 11 years and 59% among adolescents aged 12 to 15 years, according to data published Friday in MMWR.

Treatment for children with nonsevere tuberculosis can be safely shortened from 6 to 4 months, according to the results of a study published this week in The New England Journal of Medicine.